Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
Status:
Terminated
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Parkinson's disease is not only a pathology of movements. There are many non-motor symptoms
that complicate and impair patients' quality of life. Among those disorders are sleep
disorders.
Insomnia is the most frequent symptom. Most patients report 2-5 awakenings per night and long
periods of awakening which occupy 30 to 40% of their night.
Apomorphine is a dopamine agonist that may be administered with a pump . The objective of the
study is to assess changes in the quality of sleep in Parkinson's disease patients treated
with an apomorphine pump.